Literature DB >> 19396523

Anti-interferon-gamma autoantibody in a patient with disseminated Mycobacterium avium complex.

Toshiyuki Koya1, Chikako Tsubata, Hiroshi Kagamu, Ken-ichi Koyama, Masachika Hayashi, Katsuhiro Kuwabara, Takui Itoh, Yoshinari Tanabe, Toshinori Takada, Fumitake Gejyo.   

Abstract

We report the case of a 44-year-old woman with disseminated Mycobacterium avium complex (MAC) infection involving multiple bone lesions despite a normal healthy status until 6 months previously. Because she was suspected to have acquired immunodeficiency, we tested interferon (IFN)-gamma production by peripheral blood mononuclear cells (PBMC) after phytohemagglutinin (PHA) or anti-CD3 stimulation, and found that these cells produced no, or undetectable, levels of IFN-gamma in the presence of the patient's plasma, but produced nearly normal levels of IFN-gamma in the presence of healthy donor plasma. Since the IgG fraction of the patient's plasma was capable of blocking in vitro responses to IFN-gamma, the cause of disseminated MAC infection in this case appeared to be anti-IFN-gamma autoantibodies. To reduce the titer of anti-IFN-gamma autoantibodies, the patient received intravenous immunoglobulin (IVIG). However, titer of autoantibodies changed little compared to that before IVIG administration. According to our literature search, this is only the second case of disseminated MAC infection associated with anti-IFN-gamma autoantibodies in Japan.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19396523     DOI: 10.1007/s10156-008-0662-8

Source DB:  PubMed          Journal:  J Infect Chemother        ISSN: 1341-321X            Impact factor:   2.211


  37 in total

1.  Anti-CD20 (rituximab) therapy for anti-IFN-γ autoantibody-associated nontuberculous mycobacterial infection.

Authors:  Sarah K Browne; Rifat Zaman; Elizabeth P Sampaio; Kamonwan Jutivorakool; Lindsey B Rosen; Li Ding; Minjal J Pancholi; Lauren M Yang; Debra Long Priel; Gulbu Uzel; Alexandra F Freeman; Carlton E Hayes; Roger Baxter; Stuart H Cohen; Steven M Holland
Journal:  Blood       Date:  2012-03-08       Impact factor: 22.113

2.  Late-Onset Disseminated Mycobacterium avium intracellulare Complex Infection (MAC), Cerebral Toxoplasmosis and Salmonella Sepsis in a German Caucasian Patient with Unusual Anti-Interferon-Gamma IgG1 Autoantibodies.

Authors:  Leif G Hanitsch; Madlen Löbel; Holger Müller-Redetzky; Mariana Schürmann; Norbert Suttorp; Nadine Unterwalder; Ulrike Mönnich; Christian Meisel; Kirsten Wittke; Hans-Dieter Volk; Carmen Scheibenbogen; Uwe Kölsch
Journal:  J Clin Immunol       Date:  2015-04-15       Impact factor: 8.317

3.  Recurrent Burkholderia gladioli suppurative lymphadenitis associated with neutralizing anti-IL-12p70 autoantibodies.

Authors:  Bich-Thuy T Sim; Sarah K Browne; Marguerite Vigliani; Dalila Zachary; Lindsey Rosen; Steven M Holland; Steven M Opal
Journal:  J Clin Immunol       Date:  2013-05-26       Impact factor: 8.317

4.  Natural History and Evolution of Anti-Interferon-γ Autoantibody-Associated Immunodeficiency Syndrome in Thailand and the United States.

Authors:  Gloria H Hong; Ana M Ortega-Villa; Sally Hunsberger; Ploenchan Chetchotisakd; Siriluck Anunnatsiri; Piroon Mootsikapun; Lindsey B Rosen; Christa S Zerbe; Steven M Holland
Journal:  Clin Infect Dis       Date:  2020-06-24       Impact factor: 9.079

5.  Recurrence of disseminated Mycobacterium avium complex disease in a patient with anti-gamma interferon autoantibodies by reinfection.

Authors:  Tomoyasu Nishimura; Yukiko Fujita-Suzuki; Makoto Yonemaru; Kiyofumi Ohkusu; Takuro Sakagami; Stephen M Carpenter; Yoshihito Otsuka; Ho Namkoong; Ikuya Yano; Naoki Hasegawa
Journal:  J Clin Microbiol       Date:  2015-02-04       Impact factor: 5.948

6.  Disseminated penicilliosis, recurrent bacteremic nontyphoidal salmonellosis, and burkholderiosis associated with acquired immunodeficiency due to autoantibody against gamma interferon.

Authors:  Bone Siu-Fai Tang; Jasper Fuk-Woo Chan; Min Chen; Owen Tak-Yin Tsang; M Y Mok; Raymond Wai-Man Lai; Rodney Lee; Tak-Lun Que; Herman Tse; Iris Wai-Sum Li; Kelvin Kai-Wang To; Vincent Chi-Chung Cheng; Eric Yuk-Tat Chan; Bojian Zheng; Kwok-Yung Yuen
Journal:  Clin Vaccine Immunol       Date:  2010-05-05

7.  Rituximab as successful adjunct treatment in a patient with disseminated nontuberculous mycobacterial infection due to acquired anti-interferon-γ autoantibody.

Authors:  Christopher A Czaja; Patricia A Merkel; Edward D Chan; Laurel L Lenz; Molly L Wolf; Rafeul Alam; Stephen K Frankel; Aryeh Fischer; Shaila Gogate; Carlos M Perez-Velez; Vijaya Knight
Journal:  Clin Infect Dis       Date:  2013-12-11       Impact factor: 9.079

Review 8.  Anti-interferon-γ autoantibody and opportunistic infections: case series and review of the literature.

Authors:  T Kampitak; G Suwanpimolkul; S Browne; C Suankratay
Journal:  Infection       Date:  2010-12-03       Impact factor: 3.553

9.  Autoimmunity as a predisposition for infectious diseases.

Authors:  Mohan S Maddur; Janakiraman Vani; Sébastien Lacroix-Desmazes; Srinivas Kaveri; Jagadeesh Bayry
Journal:  PLoS Pathog       Date:  2010-11-04       Impact factor: 6.823

10.  Adult-onset immunodeficiency in Thailand and Taiwan.

Authors:  Sarah K Browne; Peter D Burbelo; Ploenchan Chetchotisakd; Yupin Suputtamongkol; Sasisopin Kiertiburanakul; Pamela A Shaw; Jennifer L Kirk; Kamonwan Jutivorakool; Rifat Zaman; Li Ding; Amy P Hsu; Smita Y Patel; Kenneth N Olivier; Viraphong Lulitanond; Piroon Mootsikapun; Siriluck Anunnatsiri; Nasikarn Angkasekwinai; Boonmee Sathapatayavongs; Po-Ren Hsueh; Chi-Chang Shieh; Margaret R Brown; Wanna Thongnoppakhun; Reginald Claypool; Elizabeth P Sampaio; Charin Thepthai; Duangdao Waywa; Camilla Dacombe; Yona Reizes; Adrian M Zelazny; Paul Saleeb; Lindsey B Rosen; Allen Mo; Michael Iadarola; Steven M Holland
Journal:  N Engl J Med       Date:  2012-08-23       Impact factor: 91.245

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.